Machine learning-based gastric cancer risk prediction in an asymptomatic screening population: a retrospective cohort study

Journal of Gastrointestinal Oncology · Published 2026-06-01 · DOI 10.21037/jgo-2026-0245

Free full text

Authors (8)

Ji Hyun Song, San Wang, Young Sun Kim, Sun Young Yang, Hae Yeon Kang, Marharyta Kurban, Sanghee Lim, Jeong Yoon Yim

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Song, J., Wang, S., Kim, Y., et al. (2026). Machine learning-based gastric cancer risk prediction in an asymptomatic screening population: a retrospective cohort study. Journal of Gastrointestinal Oncology. https://doi.org/10.21037/jgo-2026-0245

Related articles

• Th1–2 immune balance revisited: refining prognostic immune signatures in colorectal cancer · Journal of Gastrointestinal Oncology · 2026 · Same journal
• From prediction to judgment: what a five-variable nomogram teaches us about hepatocellular carcinoma · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Revisiting prognostic biomarkers in gastrointestinal stromal tumor: the potential role of ETV1 polymorphisms · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Prognostic and therapeutic significance of microscopic tumor focus in combined hepatocellular-cholangiocarcinoma: a multicenter pathological study · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Efficacy and safety of modified FLOT chemotherapy in gastric or gastroesophageal junction adenocarcinoma: a retrospective cohort study · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Is the time of ethanol injection over?—has endoscopic ultrasonography-guided radiofrequency ablation become the preferred approach for small pancreatic neuroendocrine tumors? · Journal of Gastrointestinal Oncology · 2026 · Same journal
• A hub for an herb: is STAT3 blockade at the epicenter of toosendanin-induced NCOA4-dependent ferritinophagy and ferroptosis in cancer cells? · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Real-world feasibility and safety of neoadjuvant FOLFIRINOX in pancreatic ductal adenocarcinoma: a retrospective single-center study · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Association between surgical timing and postoperative outcome in patients with residual esophageal cancer after neoadjuvant chemoradiotherapy · Journal of Gastrointestinal Oncology · 2026 · Same journal
• Natural product-based nanoengineering in gastrointestinal stromal tumors: early promise and translational challenges · Journal of Gastrointestinal Oncology · 2026 · Same journal